Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus
出版年份 2018 全文链接
标题
Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume 20, Issue 12, Pages 1649-1652
出版商
Wiley
发表日期
2018-10-03
DOI
10.1002/ejhf.1318
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
- (2017) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes
- (2016) Csaba Mátyás et al. EUROPEAN JOURNAL OF HEART FAILURE
- The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
- (2015) Csaba Mátyás et al. Cardiovascular Diabetology
- PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
- (2015) Anindita Das et al. PHARMACOLOGY & THERAPEUTICS
- Crosstalk between fibroblasts and inflammatory cells
- (2014) S. Van Linthout et al. CARDIOVASCULAR RESEARCH
- Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)
- (2014) Diana Bonderman et al. CHEST
- Gigantic Business
- (2014) Wolfgang A. Linke et al. CIRCULATION RESEARCH
- Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes
- (2014) Brian R. Lindman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
- (2013) Nazha Hamdani et al. Circulation-Heart Failure
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
- (2013) Stephen J. Greene et al. Journal of the American Heart Association
- Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy
- (2012) Elisa Giannetta et al. CIRCULATION
- Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
- (2012) Loek van Heerebeek et al. CIRCULATION
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Diastolic Stiffness of the Failing Diabetic Heart
- (2007) Loek van Heerebeek et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now